title: Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients.
authors.affiliation: DUMC, Durham, NC 27710.
authors.forename: R C
authors.initials: RC
authors.lastname: Harland
authors.forename: W B
authors.initials: WB
authors.lastname: Vernon
authors.forename: H
authors.initials: H
authors.lastname: Bunzendahl
authors.forename: J K
authors.initials: JK
authors.lastname: Thompson
authors.forename: C
authors.initials: C
authors.lastname: Lawrence
authors.forename: R R
authors.initials: RR
authors.lastname: Bollinger
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000627:therapeutic use*; D006084:Graft Rejection; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D016035:Pancreas Transplantation
chemical_list: D015774:Ganciclovir; D000212:Acyclovir